WHO’s Strategic Advisory Group of Experts (SAGE) has published interim recommendations for using the Moderna COVID-19 vaccine (mRNA-1273) in epidemic prevention.
Who should be prioritized for vaccination?
Vaccination should be emphasized for healthcare personnel, the elderly, and groups disproportionately affected by COVID-19.
Other priority subjects
People with chronic lung disease, heart disease, obesity, diabetes, liver disease, and HIV have been recognized as having a significant risk of serious consequences if infected with COVID-19. This group of persons should be vaccinated as soon as possible.
Immunocompromised individuals are also a priority group. Although further research is required to achieve more specific and accurate conclusions, immunocompromised people can be immunized against COVID-19 after receiving information and advice.
HIV patients who get COVID-19 are at risk of serious consequences. Individuals who have tested positive for HIV should be given information and counseling prior to vaccination.
People who have previously been infected with COVID-19 are also eligible for vaccination. However, immunization may be delayed for up to 6 months following SARS-CoV-2 infection.
The vaccine’s efficacy in breastfeeding women is likely to be comparable to that in other adults. Breastfeeding mothers should be vaccinated against COVID-19 just like everyone else, and they do not need to cease breastfeeding following vaccination.
Should pregnant women be vaccinated?
The World Health Organization recommends that pregnant women get vaccinated against COVID-19 if the benefits outweigh the risks. To assist pregnant women in the assessment and decision-making process, they should be given information regarding the risks of COVID-19 during pregnancy, the benefits of vaccination in light of the local epidemic, and other relevant information. The World Health Organization does not promote pregnancy testing prior to vaccination, nor does it advise delaying or terminating pregnancy for vaccine purposes.
Who should not be vaccinated?
Individuals with a history of severe allergic reaction to any component of the vaccine should not receive the Moderna vaccine or any other mRNA vaccine.
Elderly people are prioritized for vaccination due to the high risk of severe disease and death. However, for elderly people with particularly weak health and a prognosis of less than 3 months to live, specific assessment is needed. possible in each case.
According to current research results, do not vaccinate people under 18 years of age with the Moderna vaccine.
Recommended dose
SAGE recommends that each individual receive 2 doses of Moderna mRNA-1273 vaccine (each 100 µg, 0.5 ml) 28 days apart, which can be increased to 42 days if necessary.
Is Moderna mRNA-1273 vaccine safe?
On April 30, the World Health Organization added the Moderna vaccine to the emergency use list after assessing its quality, safety, and effectiveness. The European Medicines Agency (EMA) also approved the use of Moderna throughout Europe after carefully reviewing evidence on the vaccine’s quality, safety, and effectiveness.
SAGE recommends that vaccine recipients remain at the vaccination facility for at least 15 minutes after injection. People who experience severe allergic responses immediately following the first injection should not receive the second injection.
How effective is the vaccine?
The Moderna vaccine provided approximately 94.1% protection against COVID-19 beginning on day 14 after the first shot.
Is Moderna effective against new strains?
According to current findings, novel SARS-CoV-2 variants, such as B.1.1.7 and 501Y.V2, do not impair the efficiency of the Moderna mRNA vaccine. The monitoring, collection, and analysis of novel variations and their impact on COVID-19 diagnostic and treatment effectiveness, as well as vaccination effectiveness, is ongoing.
Does Moderna prevent infection?
We don’t know if immunizations can protect us from infection and reduce the chance of spreading the disease to others. People who receive vaccinations are immune for several months, but there is no proof that the protection lasts indefinitely. These concerns are still being investigated.
(According to WHO) – See original here